Skip to main content

Table 1 Baseline characteristics of HF patients, MAHFER study

From: Validation of heart failure quality of life tool and usage to predict all-cause mortality in acute heart failure in Uganda: the Mbarara heart failure registry (MAHFER)

 

N = 195

Characteristic

 

 Age, mean (SD), years

52 (21.4)

 Women, n (%)

132 (67.7)

 Asset index quintiles, n (%)

  Poorest

33 (16.9)

  Poorer

32 (16.4)

  Average

34 (17.4)

  Rich

38 (19.5)

  Richest

34 (12.3)

  Missing

24 (12.3)

 Highest education level attained, n (%)

  None

73 (37.4)

  Primary

105 (53.9)

  Secondary & Tertiary

17 (8.7)

 Smoking history, n (%)

  Never smoked

153 (78.5)

  Former smoker

24 (12.3)

  Current smoker

18 (9.2)

 Alcohol use history, n (%)

  Never

19 (9.7)

  Non-hazardous

172 (88.2)

  Hazardous

4 (2.1)

Comorbid diseases

 Hypertension, n (%)

56 (28.7)

 Diabetes mellitus, n (%)

15 (7.7)

 HIV infection, n (%)

16 (8.2)

 None

108 (55.4)

 Self-reported poor medication adherence

115 (59)

Aetiology of Heart failure

 Hypertensive heart disease

42 (21.5)

 Dilated cardiomyopathies

39 (20.0)

 Ischemic heart disease

6 (3.1)

 Unknown

108 (55.4)

NYHAÂ¥ functional class at enrollment

 NYHA class I, n (%)

0 (0)

 NYHA class II, n (%)

1 (0.5)

 NYHA class III, n (%)

85 (43.6)

 NYHA class IV, n (%)

109 (55.9)

Left ventricular ejection fraction (LVEF)

 LVEF*, mean (SD)

41 (12.9)

Medication during hospital stay*, n (%)

 Furosemide

178 (91.3)

 ACEI/ARB∧

54 (27.7)

 Digoxin

45 (23.1)

 Dobutamine

20 (10.3)

Blood test

 Blood urea nitrogen (mg/dL), mean (SD)

59.6 (65.4)

 Serum Creatinine (mg/dL), mean (SD)

2.0 (2.7)

 Serum sodium (mmol/L), mean (SD)

132 (15.8)

 BNP∞(pg/mL), mean (SD)

2164 (1762)

 CKMB€ (ng/mL), mean (SD)

4.3 (10.2)

  1. SD standard deviation, NYHA¥ New York Heart Association, LVEF* Left ventricular Ejection fraction, HIV Human Immunodeficiency virus, ACEI/ARB∧ Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker, BNP∞ Brain Natriuretic Peptide, CKMB€ Creatine-Kinase (MB isomer)
  2. *Most participants took multiple medications thus the percentages of medications add up to more than 100%